172014Mar

Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial

This article examined the relationship between CoQ10 and inflammatory markers involved in multiple sclerosis (MS), where subjects receiving 500mg of CoQ10 per day for 12 weeks, showed reductions in (tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and matrix metalloproteinase (MMP)-9) inflammatory markers. We know inflammation drives the development of MS and auto-immune disorders, so any reduction in inflammation would not only benefit MS patients, but anyone taking CoQ10. CoQ10 is critical for the production of energy in the body and as an anti-oxidant which helps numerous systems in the body work efficiently. There are many studies on CoQ10 and its benefits for cardiovascular / mitochondrial /neurological diseases, as well as numerous others.

Nutr Neurosci. 2014 Jan 10. [Epub ahead of print]

http://www.ncbi.nlm.nih.gov/pubmed/24621064